Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 18.30
+0.28 (+1.55%)
(As of 11/1/2024 ET)

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, MXCT, HZD, and NIOX

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), MaxCyte (MXCT), Horizon Discovery Group plc (HZD.L) (HZD), and NIOX Group (NIOX). These companies are all part of the "medical" sector.

BATM Advanced Communications vs.

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Tristel has a net margin of 15.29% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.35% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.29% 20.35% 9.89%
BATM Advanced Communications -0.21%-0.17%0.58%

50.4% of Tristel shares are owned by institutional investors. Comparatively, 42.4% of BATM Advanced Communications shares are owned by institutional investors. 4.9% of Tristel shares are owned by insiders. Comparatively, 26.2% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£39.49M5.07£6.04M£0.133,230.77
BATM Advanced Communications£122.70M0.65£2.51MN/AN/A

In the previous week, Tristel and Tristel both had 1 articles in the media. BATM Advanced Communications' average media sentiment score of 0.00 beat Tristel's score of -1.02 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tristel
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
BATM Advanced Communications
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tristel has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500.

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.1%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.5%. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Tristel beats BATM Advanced Communications on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£79.82M£2.68B£5.40B£1.58B
Dividend Yield3.52%2.01%5.13%11.08%
P/E Ratio2,800.00350.49115.481,723.54
Price / Sales0.65200.671,483.20228,959.04
Price / Cash2.12134.4139.6535.69
Price / Book0.682.554.662.87
Net Income£2.51M£91.96M£119.06M£144.80M
7 Day Performance-8.50%-1.42%0.80%0.11%
1 Month Performance-6.63%-3.52%5.66%-0.16%
1 Year Performance-7.11%7.92%36.76%15.21%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 18.30
+1.6%
N/A-3.0%£79.82M£122.70M2,800.00980News Coverage
Positive News
Gap Down
TSTL
Tristel
N/AGBX 361.50
+3.3%
N/A+2.6%£172.26M£39.49M2,780.77208Negative News
SPEC
INSPECS Group
N/AGBX 53.88
-0.2%
N/A-27.3%£54.78M£195.14M-17.551,673
AKR
Akers Biosciences
N/AGBX 57.50
flat
N/A+0.0%£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.36
+1.8%
N/AN/A£8.00M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AGBX 2.20
flat
N/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
2.82 of 5 stars
GBX 221.80
-1.0%
GBX 301.25
+35.8%
+4.4%£4.55B£2.20B3,696.6710,000News Coverage
AMS
Advanced Medical Solutions Group
2.6711 of 5 stars
GBX 198.40
+0.7%
GBX 300
+51.2%
+12.8%£425.67M£131.11M3,968.0010News Coverage
MXCT
MaxCyte
N/AGBX 290
+1.8%
N/A+15.9%£304.76M£45.44M-1,115.3880News Coverage
HZD
Horizon Discovery Group plc (HZD.L)
N/AGBX 184.50
flat
N/A+0.0%£302.98M£54.63M-33.55416
NIOX
NIOX Group
N/AGBX 62.15
+0.6%
N/A-2.1%£263.60M£39M3,107.5092

Related Companies and Tools


This page (LON:BVC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners